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Abstract 
 
 Cognitive-behavioral therapy (CBT), which encompasses exposure with response 
prevention (ERP) and cognitive therapy, has demonstrated efficacy in the treatment of 
obsessive-compulsive disorder (OCD). However, the samples studied (reflecting the 
heterogeneity of OCD), the interventions examined (reflecting the heterogeneity of 
CBT), and the definitions of treatment response vary considerably across studies. This 
review examined the meta-analyses conducted on ERP and cognitive therapy (CT) for 
OCD.  Also examined was the available research on long-term outcome associated with 
ERP and CT.  The available research indicates that ERP is the first line evidence based 
psychotherapeutic treatment for OCD and that concurrent administration of cognitive 
therapy that targets specific symptom-related difficulties characteristic of OCD may 
improve tolerance of distress, symptom-related dysfunctional beliefs, adherence to 
treatment, and reduce drop out.  Recommendations are provided for treatment delivery 
for OCD in general practice and other service delivery settings.  The literature suggests 
that ERP and CT may be delivered in a wide range of clinical settings.  Although the data 
are not extensive, the available research suggests that treatment gains following ERP 
are durable.  Suggestions for future research to refine therapeutic outcome are also 
considered.   
 
Keywords: obsessive-compulsive disorder; exposure with response prevention; 
cognitive therapy; meta-analysis; treatment adherence 
 
1. Introduction 
Obsessive-compulsive disorder (OCD) is widely recognized as a serious and 
debilitating psychiatric condition (e.g., Markarian, et al., 2010). The disorder is marked 
by three distinct components.  One component, obsessions, has been defined as 
intrusive and unwanted thoughts, images or ideas, as well as doubts about actions.  
Obsessions are typically in specific areas such as horrific images (such as blasphemy, 
sexual ideas, or violent images), thoughts of contamination, or doubts relating to 
whether some action was not completed.  The second component, compulsions, has 
been defined as specific behavioral actions, including covert mental rituals, intended to 
neutralize the obsessions, or to verify behaviors that are the subject of doubts.  In 
addition to these two primary components, individuals with the disorder engage in 
extensive avoidance to prevent the provocation of obsessions and their associated 
compulsions.  A diagnosis of OCD has serious implications for the sufferer as the 
disorder is associated with extensive disability covering virtually all aspects of 
functioning, increased healthcare utilization, and reduced quality of life (Markarian et 
al., 2010). 
 Since Meyer (1966) first described treatment employing exposure with response 
prevention (ERP), cognitive behavioral therapy (CBT)
1
 has been refined for OCD to the 
point that this approach is considered the most efficacious psychotherapeutic method 
of treating the disorder.  In Meyer’s original report, he described two cases of OCD, one 
with checking symptoms to ensure that clothing and other objects used by her baby 
were not dirty.  The other case was marked by intrusive and unwanted sexual and 
blasphemous thoughts, with accompanying ritualistic behavior to annul these 
obsessions. These two case studies illustrate the heterogeneity of OCD.  First, as 
                                                           
1
 We rely on the broad term CBT to reflect treatment protocols that integrate exposure based treatment 
with cognitive therapy approaches.  Throughout the manuscript, exposure-based treatment will be 
referred to as exposure with response prevention (ERP) and cognitive therapy (CT) will be used to refer to  
protocols that emphasize cognitive-restructuring and that may include behavioral experiments but do not 
utilize exposure as central to treatment.  
demonstrated by extensive research, OCD is marked by different symptom dimensions 
(McKay et al., 2004; Abramowitz, McKay, and Taylor, 2005). Factor and cluster analytic 
research has shown that OCD is comprised of the following broad dimensions: 
obsessions (aggressive, sexual, religious, somatic) and checking compulsions; symmetry 
obsessions and ordering, counting, and repeating compulsions; contamination 
obsessions and cleaning compulsions; and hoarding.
2
  In addition to these dimensions, 
there is a wide range of common complicating symptoms associated with the disorder, 
such as comorbid depression, comorbid anxiety disorders, and overvalued ideas 
(Abramowitz, McKay, and Taylor, 2008a; Abramowitz, McKay, and Taylor, 2008b). As a 
result, the treatment literature on OCD, while emphasizing the efficacy of CBT broadly 
defined, does not necessarily provide a straightforward summary of treatment decisions 
for practitioners.  Further, in light of the heterogeneity of OCD symptoms (McKay et al., 
2004), there is little data examining specific symptom presentations, further 
complicating any treatment guideline endeavor.  For example, it has been suggested 
that primarily mental obsessions have a more chronic course (Sibrava et al., 2011) 
necessitating a longer course of therapy.  Some post-hoc analyses have suggested 
                                                           
2
 With the development of the fifth edition of the Diagnostic and Statistical Manual (DSM-5; 
APA, 2013) hoarding is now a separate disorder within a broader new category, the Obsessive-
Compulsive Related Disorders.  This change is the result of extensive research showing that 
hoarding has substantially different pathophysiological, cognitive, behavioral, and 
neuropsychological symptom profiles from other OCD symptoms (Pertusa et al., 2008; Pertusa 
et al., 2010; Mataix-Cols et al., 2010), is associated with specific symptom profiles (Mogan et 
al., 2012) and poorer treatment response when therapy is similar to that employed for OCD 
(Abramowitz et al., 2003), and is best explained by a different conceptual model of etiology and 
maintenance (Frost, 1996). However, hoarding behaviors that are in response to obsessions will 
still be part of OCD  
 
differential treatment outcome based on symptom dimension (i.e., Abramowitz et al., 
2003), which would also suggest some specific guidelines.  Further still, recent research 
has suggested that significant heterogeneity exists within dimensions.  For example, 
contamination fear is considered one of the more readily treated symptoms of OCD 
(Abramowitz et al., 2003).  Yet, it has also been shown that contamination fear is often 
marked by significant disgust, rather than fear, and the response to exposure for disgust 
is lower than for anxiety (McKay, 2006).  As a more general indicator, it has been shown 
that disgust may be associated with higher levels of intrusive images that are, in turn, 
more difficult to treat using existing CBT methods. 
 Given the heterogeneity of the condition, clinicians would benefit from a 
systematic set of guidelines derived from the existing CBT literature, There are two 
major aims of this paper.  The first is to summarize the efficacy of CBT for OCD based on 
existing meta-analyses.  This includes a refinement over previous guidelines by 
highlighting specific predictors of treatment response in order that clinicians may better 
anticipate factors that require additional clinical intervention to improve outcome.  
Mechanisms hypothesized to underlie ERP, and its efficacy, as well as mechanisms 
thought to underlie cognitive therapy (CT) and its efficacy are presented.  The second 
aim is to articulate a research agenda for further refining the guidelines offered here, in 
light of the complexity of the disorder. These aims were undertaken with the objective 
of clearly illustrating the range of outcomes that could be expected when employing 
CBT for OCD, providing recommendations for standards of care, and describing areas of 
future investigation. 
2. Exposure with Response Prevention 
 As noted above, the first cognitive-behavioral intervention for OCD was ERP.  
Treatment using this approach involves developing a hierarchy of presenting symptoms, 
from least fear producing to most, and then guiding the client through exposure to 
items on the hierarchy until the highest level items are readily tolerated.  In parallel, 
response prevention is included, whereby the client is asked to refrain from completing 
the compulsions that would otherwise eliminate the anxiety or distressing emotional 
reaction, or by re-applying the exposure to the fear stimulus immediately following the 
completion of compulsions (Rowa, Antony, and Swinson, 2007).   To illustrate, in the 
treatment of contamination fears, exposure would center on feared contaminating 
stimuli.  The individual is asked to stop washing rituals. However, if the individual “slips” 
and washes, re-contamination would be recommended immediately following.  In the 
strictest sense, ERP involves exposure to the feared stimuli, and then effectively 
‘waiting’ for the anxiety to subside through habituation.  However, there are variations 
in how ERP is conducted, including efforts to enhance the intensity of the exposure 
experience via clinician-assisted imagery.  
 
2.1 Hypothesized Action of Exposure with Response Prevention, and Barriers to 
Implementation: In the original case illustrations of OCD treatment, and subsequent 
behavioral conceptualizations, OCD was considered as a disorder acquired through 
classically conditioned fear responses, and maintained through negatively reinforced 
avoidance responses (Mowrer, 1960).  However, it was observed that many individuals 
with OCD had symptoms that showed remarkable persistence despite adherence to 
treatment with ERP (Foa et al., 1983).  As a result, further examination revealed several 
important factors to maximize the efficacy of ERP.  The central target in any exposure 
treatment is the fear structure that is stored in memory (Foa and Kozak, 1986).  This 
requires satisfaction of several criteria. First, exposure should be conducted that is 
sufficiently arousing that it activates the fear structure, but not so arousing that new 
learning cannot be accomplished.  To illustrate, moving too quickly up the fear hierarchy 
can lead to intense emotional arousal where the exposure itself sensitizes the fear 
structure and the situation is escaped before any habituation may occur.  Second, since 
humans seek safety information, efforts to manipulate the exposure exercise to 
minimize its impact should be addressed by the clinician. Foa and Kozak provided a 
particularly clear illustration of this effect with a client suffering from contamination 
fear: 
“During exposure sessions urine was put on several places on his arm. A 
strong initial fear reaction was manifested in nervous movements, 
blushing, and a very high anxiety rating. However, unlike the gradual 
reduction of anxiety observed in most patients, a sharp response 
decrement (within 3-5 min) was observed with this patient. This pattern 
of high initial response followed by rapid decline was repeated daily: 
Long-term habituation was not evident. Inquiry revealed a curious 
avoidance technique: In his imagination this patient first "froze" the 
contaminated spots to prevent their "spread"; having controlled them he 
stopped attending to them. In this case, the observed response decrease 
seemed not to reflect therapeutic emotional processing but rather, 
successful avoidance of the contaminant.” (Foa and Kozak, 1986, p. 30) 
 
This illustrates the act of cognitive avoidance that may occur in ERP.  Therefore, 
interventions involving ERP require ongoing assessment on the part of the clinician to 
address this special kind of avoidance in order to produce therapeutic benefit.  Since the 
time of this conceptualization, it has been found that many individuals with OCD also 
engage in covert rituals (Purdon, 2008) that warrant specific treatment attention.   
 Whereas clients may strategically and automatically engage in avoidance 
responses, other prevailing emotional states, notably depression, further interfere with 
emotional processing.  This has been borne out in additional research, with comorbid 
depression often shown to be a specific poor prognostic indicator for treatment 
outcome in OCD (Abramowitz et al., 2007; Keeley et al., 2008) although some studies 
have failed to replicate the prognostic value of depression in pharmacological treatment 
studies (Mawson, Marks, and Ramm, 1982) or naturalistic follow-up studies (Zitterl et 
al., 2000). There are several hypotheses for the purported poorer response, although 
none has been extensively evaluated.  One is that clients with OCD and comorbid 
depression are over reactive to ERP, which in turn hinders habituation (Abramowitz, 
2004).  Another hypothesis is that depression in individuals with OCD leads to poorer 
motivation for treatment, particularly given the demands of ERP (Keeley et al., 2008).  
And finally, it has been suggested that depression leads to an increased risk for 
obsessional experiences (Abramowitz et al., 2007).   
 An additional prognostic indicator that has been described is overvalued 
ideation.  Foa and Kozak (1986, 1994) identified overvalued ideas as a client factor that 
interferes with emotional processing during exposure.  Overvalued ideation has been 
defined as a transient psychotic feature whereby the accuracy of the obsessions, or the 
necessity of the associated compulsions, is deemed essential rather than irrational 
(Kozak and Foa, 1994).  It has been noted that overvalued ideas with associated 
impaired insight interfere with disconfirmatory learning, ability to achieve habituation, 
and potentially may instead further sensitize clients when faced with feared situations 
they have difficulty reappraising. Overvalued ideas have also been conceptualized as 
rigid beliefs derived from idealized values that are over-identified with the self (Veale, 
2002).  The presence of overvalued ideas has been associated with poor treatment 
response (e.g., Neziroglu et al., 2001; Neziroglu et al., 2004). In fact, it has been 
reported that OCD individuals with high overvalued ideas, as assessed by the 
Overvalued Ideas Scale (OVIS: Neziroglu et al., 1999), do not significantly differ from 
schizophrenic patients on tests of cognitive functioning (Catapano et al., 2010), and they 
display more extensive cognitive dysfunction on tests of verbal learning and memory 
(Kitis et al., 2007).  
Among client-related specific prognostic indicators, an important and under 
examined component of treatment efficacy is patient adherence.  Recent research has 
shown patient adherence to treatment significantly predicted both acute and long-term 
outcome in both completers and intent-to-treat patients (Simpson et al., 2011; Simpson 
et al., 2012). Moreover, data suggest that other predictors of outcome (e.g., baseline 
OCD severity, hoarding subtype, working alliance, readiness for treatment) may impact 
outcome through their effects on patient adherence (Simpson et al., 2011; Maher et al., 
2012).  Other client-related variables have also been found to contribute small but 
additive effects to predicting ERP outcome (i.e., comorbidity, prior medication trials, and 
quality of life (Maher et al., 2010)).  
 2.2 Efficacy of Exposure with Response Prevention – Meta-Analytic Findings:  There have 
been several quantitative evaluations of the efficacy of ERP for OCD.  The first 
evaluation, by Christensen et al. (1987) showed ERP to be efficacious (mean d=1.30).  
However, at the time of this evaluation, some categories had very few studies for 
calculation of effect sizes (i.e., live exposure, or exposure in vivo) and all comparisons 
were against a wait-list control group.  Abramowitz (1997) conducted a meta-analysis, at 
the point where ERP had been compared to “active”
3
 control conditions such as 
relaxation training and found that ERP continued to demonstrate large effect sizes for 
efficacy compared to relaxation training (mean d=1.18).  In another meta-analysis (van 
Balkom et al., 1994) the effect sizes for several different self-report measures and 
behavioral and observer assessments were generally large regardless of method of 
outcome evaluation.  
 Abramowitz (1996) further evaluated the differential efficacy of specific methods 
of exposure delivery. Studies and approach to conducting exposure were divided into 
four categories: therapist supervised exposure or independently conducted by client; in 
vivo or in imagery; stimuli physically presented according to the hierarchy or not; 
complete or partial ritual prevention. There were several important findings.  First, 
therapist controlled administration of ERP was associated with significantly greater 
symptom reduction at post-treatment (mean d=1.58) and follow-up (mean d=1.47) 
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 Relaxation training has been utilized as a credible attention control group; however, it has also been 
shown that relaxation training has generally a medium effect in reducing anxiety symptoms (Manzoni et 
al., 2008). 
compared to that conducted independently (i.e., by self-guided interventions) by clients.  
Second, total response prevention was associated with significantly greater symptom 
reduction than partial response prevention at post treatment (mean d=1.67) and follow-
up (mean d=1.46).  Third, exposure in vivo was significantly more effective when 
accompanied by imagery that was developed by the clinician to enhance the live 
exposure (mean d=2.76) compared to in vivo alone.  Finally, there was no difference in 
efficacy of symptom reduction for gradual exposure compared to a more rapid increase 
in stimulus exposure intensity, with both resulting in significant improvement (all mean 
ds > 1.33).  Recent analyses have continued to support the efficacy of in vivo with 
imaginal exposure for OCD compared to either wait list or attention control groups 
(mean d=1.30)( Rosa-Alcázar, et al., 2008).  Rosa-Alcázar, et al. (2008) also showed that 
therapist-guided ERP produced substantial benefits on measures of depression in OCD 
(mean d=0.78).  
2.2.1 Summary of Exposure with Response Prevention Meta-Analytic Findings:  
Over the past several decades, considerable research has accumulated to show that ERP 
is an efficacious intervention for OCD.  The method of delivery is important with in vivo 
therapist –assisted ERP, in conjunction with imagery, producing the greatest change in 
symptom severity.  At the same time, there is a range of outcomes (due to 
aforementioned factors such as patient adherence to therapy) ranging from recovery, 
minimal residual symptoms, partial response, or little benefit in some cases. As these 
and other authors have pointed out, RCT’s are generally time-limited and manualized, 
however, an optimal trial of CBT for OCD requires considerably longer than three 
months. A major difficulty with RCT’s in this field is that “recovery” rates are 
insufficiently examined and have not yet been standardized (please see below for 
examination of recovery rates). Further, although evidence based treatments are 
available there is a well-documented and urgent shortage of professionals qualified to 
deliver these. 
3. Cognitive Therapy 
 Cognitive therapy (CT) developed from the position that specific dysfunctional 
beliefs promote problematic behaviors.  The philosophical roots arise from Epictitus, 
who postulated that no event is good or bad, only our statements regarding the event 
makes it good or bad (Ellis, 1994). The theoretical basis of this model, that cognition 
precedes behavior (Lazarus, 1984) sets the stage for CT.  The essential feature of 
treatment is the identification and modification of dysfunctional appraisals of intrusions 
and symptom-related beliefs in order to impact problematic behavior (Beck, Rush, and 
Shaw, 1979).  Measures of different “levels” of cognition characteristic  of OCD have 
been developed and are widely used to assess pre-treatment and cognitive changes 
following treatment : The Interpretation of Intrusions Inventory, Obsessive Beliefs 
Questionnaire (Obsessive Compulsive Cognitions Working Group, 2001, 2003), and 
Vulnerability Schemata Scale (Sookman, Pinard, and Beck, 2001). 
 
3.1 Hypothesized Action of Cognitive Therapy Efficacy, and Barriers to Implementation:  
There are several cognitive models of OCD (detailed in Taylor, Abramowitz, and McKay, 
2007).  While all emphasize symptom reduction, some recent models also incorporate 
methods that focus on identity, values, attachment style and/or alternative cognitive 
styles (Guidano and Liotti, 1983; Doron and Kyrios, 2005; Bhar and Kyrios, 2007; 
O’Connor et al., 2009; Twohig, 2009; Sookman and Steketee, 2010).  However, the 
model described by Salkovskis (1985) is the best known.  In this approach to treating 
OCD, identification of a higher order cognitive process referred to as inflated 
responsibility is the target for change.  Inflated responsibility is germane to the disorder 
by way of a system of appraising the significance of thoughts.   
 Experimental tests of this appraisal model have been supportive of the relation 
between inflated responsibility and emotional reactions.  For example, Lopatka and 
Rachman (1995) found an association between the level of perceived responsibility for 
actions and checking behaviors.  The effect of inflated responsibility in influencing 
obsessive-compulsive behaviors has been replicated, and is especially pronounced in 
individuals with OCD and checking compulsions (Foa et al., 2002).   
 Additional clinical observations have revealed that many OCD sufferers report 
varied appraisals of intrusions, and symptom – related dysfunctional beliefs that do not 
involve inflated responsibility (e.g., washers who “feel” contaminated or experience 
disgust without fear of contracting or spreading illness).  Several other appraisals/beliefs 
have been identified, that include: overestimation of threat; overimportance of 
thoughts; intolerance of uncertainty; importance and control over thoughts; and 
perfectionism (Obsessive Compulsive Cognitions Working Group, 2001, 2003).  These 
cognitive appraisals extend to evaluations of the implications of having specific thoughts 
(i.e., obsessions).  For example, individuals with intrusive aggressive thoughts may then 
evaluate the significance, meaning, perceived threat, and feared consequences of 
having aggressive thoughts.  These belief domains and associated appraisals are 
considered central in the contemporary CT methods for OCD (Wilhelm & Steketee, 
2006).  Based on this description it is important to recognize that CT for OCD is specific 
when compared to the more general CT developed originally by Beck et al. (1979), for 
example, emphasis on appraisals of thoughts.  To illustrate, guiding a patient with OCD 
to the conclusion that an intrusive unwanted thought of harming a loved one does not 
confer a risk that they will in fact cause harm to the individual is unique to CT for OCD.  
As part of this model, some protocols of CT for OCD involve behavioral experiments, 
whereby the patient practices engaging in a clinician-guided exercise designed to 
activate and disconfirm symptom-related dysfunctional beliefs.  Therefore in the 
example of unwanted harming thoughts, the patient may engage in a behavioral 
exercise where he/she holds a knife to a photo of a loved one and considers then the 
relative change in risk of harm befalling the loved one. 
 
3.2 Efficacy of Cognitive Therapy for Obsessive-Compulsive Disorder – Meta-Analytic 
Findings:  Cognitive therapy specifically tailored for OCD has not been available for as 
long as ERP, and so the number of treatment trials is fewer, in turn leading to fewer 
meta-analytic evaluations.  However, prior to the advent of a theoretically guided 
specific CT for OCD, treatment trials employing CT (as described, for example, by [Beck 
et al., 1979]) were conducted and summarized by van Balkom et al. (1994).  The notable 
limitation in the conclusions to be drawn from these studies is that virtually all were 
evaluations of CT with ERP
4
, making the unique effects of CT difficult to determine.  
However, the van Balkom et al. evaluation shows that there is a small and nonsignificant 
additional symptom improvement associated with the inclusion of standard CT to ERP.   
 Since that time, there have been enough trials conducted using CT based on the 
aforementioned cognitive model of OCD that meta-analyses could be conducted.  Of 
note, Rosa-Alcázar et al. (2008) showed that this form of CT was associated with larger 
effect sizes when compared to all control groups (waitlist and attention control) (mean 
d=1.09), and was not significantly different from ERP alone (mean d=1.13, nonsignificant 
in direct comparison).  However, as the authors’ point out, the effect size estimate for 
CT was derived from only three comparisons of treatment versus control groups.  
Additional research has suggested that CT for OCD is efficacious compared to wait-list 
control groups (Wilhelm et al., 2009; Belloch et al., 2010; Olatunji et al., 2013).   While 
additional research is required to examine the efficacy of CT the available evidence base 
indicates that CT should not be used on its own as a first-line treatment for OCD at this 
point; however, CT can be helpful when administered prior to and in combination with 
ERP in order to optimize change in patients’ symptom related difficulties including 
dysfunctional beliefs, tolerance of distress, improve adherence to treatment, and 
reduce drop out.  One recent study (Olatunji et al., 2013) showed that symptom 
reduction was faster with ERP than with CT, and that both groups were significantly 
improved at one-year follow-up.   
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 Behavioral experiments in CT for OCD reflects a specific type of intervention, where the desired goal is 
activation and disconfirmation of beliefs during sessions.  In many early studies, ERP was conducted 
during some sessions, and CT (as described by Beck and colleagues [1979]) during others.  We have made 
every effort to be clear about this important distinction in describing the relative efficacy of different CBT 
methods for OCD. 
 4. Variations in Treatment Implementation 
There are some points of ambiguity between ERP and CT that deserve attention.  
For example, ERP may be conducted whereby the clinician aids the patient in coming in 
contact with feared stimuli or situations followed by simply waiting until the anxiety 
subsides, in the purely in vivo format.  On the other hand, ERP where the clinician 
includes, during the exposure, imagery designed to focus on catastrophic outcomes is 
considered the most effective format (Abramowitz, 1996).  The approach where in vivo 
plus imaginal exposure is employed is designed to fully activate the fear structure to 
hasten habituation. It should be noted, however, that some patients are unable or 
unwilling to engage in imaginal exposure and this approach may not be equally suitable 
for all symptom subtypes. For example, washers may fear contamination only when 
confronted with feared stimuli in vivo, whereas individuals with checking compulsions 
may experience concerns over catastrophic consequences long after exposure is 
completed (Radomsky et al., 2010). There is one evaluation that suggests exposure 
alone produces significant change in the cognitions associated with the disorder, 
regardless of symptom type. In Belloch, Cabedo, and Carrio (2008), with a sample of 
thirty-three individuals with OCD randomly assigned to either ERP or CT alone, the 
authors found significant improvement in both groups, with slightly better outcome for 
CT.  However, of particular note in this case is that both groups showed similar levels of 
improvement on measures of appraisals (evaluated with the OBQ – 44, Obsessive 
compulsive cognitions workgroup, 2005) associated with OCD.  In a more specific test of 
whether cognitions change following ERP, Overton and Menzies (2005) treated a sample 
of fourteen clients with checking symptoms.  All clients received twelve sessions of 
ERP.  In addition to symptom ratings, all clients completed an investigator-designed 
assessment of the major cognitive appraisals noted earlier (inflated responsibility, 
overestimation of threat, overimportance of thoughts, intolerance of uncertainty, 
importance of having control over thoughts, and perfectionism).  The authors found 
that, while there was significant improvement on all symptom measures, participants 
generally remained the same on measures of cognitive appraisals associated with the 
disorder.   
 Finally, in a direct evaluation of CBT versus ERP, Whittal, Thordarson, and 
McLean (2005) found that improvement was associated with a reduction in obsessive-
compulsive beliefs, regardless of treatment approach employed.  This was observed 
when participants were assessed at pretest and posttest using the Obsessive Beliefs 
Questionnaire-44 (OCCWG, 2005) and the Interpretation of Intrusions Inventory (Frost 
and Steketee, 2002).  Again, these measures were developed to specifically evaluate 
hypothesized cognitive variables considered functional mechanisms underlying 
obsessions and the associated appraisal process.   
In summary, based on the available evidence, there appears to be value in a 
range of approaches to conducting treatment for OCD, whether ERP and/or cognitive 
therapy with behavioral experiments depending on subtype characteristics.  Indeed, as 
noted earlier, there is considerable overlap between ERP with disconfirmatory 
rationales and cognitive therapy combined with behavioral experiments (for discussion, 
see Abramowitz, McKay, & Taylor, 2005). Patients initially unable to participate in ERP 
should be offered cognitive therapy approaches specifically developed for OCD that may 
reduce intransigent beliefs, intolerance of distress, and risk aversion. Given the 
heterogeneity of symptoms in OCD, additional research is required to determine which 
approach is most suitable to what symptoms as well as further development and 
examination of strategies to achieve sustained improvement and recovery.     
   
5. Practical Aspects of Treatment Delivery 
 5.1 Durability of Treatment Gains:  The research on the long lasting effect of ERP 
and CT on OCD is limited, although all the aforementioned meta-analysis (Rosa-Alcázar 
et al., 2008) cited follow-up efficacy with large effect sizes.  Further, Ougrin (2011) 
showed that ERP and CT were each associated with large effect sizes at follow-up (6 
months or more posttreatment), although this was based on data from five studies.  
Absent from these analyses have been systematic evaluations of the duration of follow-
up and its relation to outcome.  However, the available data, while limited, is 
encouraging.  DiMauro et al. (2013) reported on three benchmarking studies where 
long-term (one year) data were reported with large effect sizes (d>1.33).  In the 
DiMauro et al. report, long-term efficacy (one year post treatment) was found in a 
general outpatient setting for a subgroup of individuals with OCD.  In studies examining 
either ERP or ERP with medication, patients who respond to treatment tended to 
sustain their improvement at follow-up.  For example, Simpson et al. (2004) found that 
patients with OCD who received and responded to ERP or ERP with clomipramine were 
maintained at three-month follow-up. Recent research continues to support the 
durability of ERP at one year posttreatment (Olatunji et al., 2013).   
 In similar fashion, the extant data suggest that treatment gains from CT are 
durable.  Van Oppen et al. (2005) found that, at five-year follow-up, 54% of patients 
with OCD who received either ERP or CT did not meet criteria for the disorder.  They 
found that there was no significant difference in level of long-term improvement 
between the ERP and CT groups.  Whittal et al. (2008) also found that treatment was 
durable, for CT and ERP, at two year follow up for patients with OCD, on measures of 
obsessive-compulsive symptoms as well as for ancillary depression symptoms. 
Additional recent research supports the long-term durability of the efficacy of CT on 
primary OCD symptoms as well as associated symptoms such as depression (Wilhelm et 
al., 2009; Belloch et al., 2010), where symptom remission was observed at one-year 
follow-up   
Several studies have reported response to combined treatments using the most 
stringent criterion for recovery of YBOCS  ≤ 7 at post treatment, that is, no longer 
meeting criteria for OCD.  In an early study of longer therapy duration, Sookman and 
Pinard (1999) reported recovery on symptoms, related beliefs, and depression of a case 
series of seven patients who had been previously unable to collaborate in ERP (mean 
duration previous CBT of 2 years). Treatment consisted of an average of 10 months of 
cognitive therapy administered prior to and during ERP.  Follow-up at nine months to 
two years indicated good maintenance of improvement. Simpson et al., 2006 reported 
that 37% (7 out of 19) of patients who received three months of cognitive behavior 
therapy (CBT) plus Anafranil had recovered.  Belloch, Cabedo & Carlo (2008) examined 
the efficacy of 6 months of ERP compared with cognitive therapy with 29 OCD patients. 
Also using the post-treatment criteria of YBOCS ≤ 7 (and at least 6 points improvement), 
8/13 (61.53%) in the ERP condition and 11/16 (68.75%) were recovered at post 
treatment. With the exception of one case in each treatment group, these results were 
maintained at one-year follow-up.  
 In summary, the long-term efficacy data suggest that treatment using ERP and 
CT are durable.  Further, based on the analysis in DiMauro et al. (2013) using a 
combination of benchmarking data and research from a general anxiety clinic, ERP and 
CT may be delivered in a general practice setting.  To further illustrate the ability to 
deliver cognitive-behavioral treatment in a general setting, Houghton et al. (2010) 
examined a naturalistic sample of individuals seeking treatment for OCD.  A total of 37 
patients were treated by eight therapists all trained in CBT for OCD, with results 
benchmarked against existing RCTs for the condition.  At posttreatment, patients 
improved an average of 45.5% for acute OCD symptoms assessed with the Y-BOCS.  No 
other symptom measures were reported.  The authors concluded that in routine clinical 
practice employing CBT, patient outcomes are comparable to that obtained in 
standardized clinical trials.  The sample in this study was variable, with the majority 
(86.5%) presenting with comorbid conditions.  The most effective methods of 
dissemination of expertise by specialists to community sites require further 
examination, and are among the crucial mandates of the CIOCD Accreditation Task 
Force. Of course, it should be recognized that an average symptom decrease of 45.5% 
leaves much to be desired with respect to treatment outcome for OCD. 
 5.2 Dimensions of Obsessive-Compulsive Disorder and Treatment Outcome:  As 
noted earlier, OCD is a heterogeneous disorder, generally considered comprised of 
different symptom dimensions.  These dimensions (aggressive, sexual, religious, somatic 
obsessions) and checking compulsions; symmetry obsessions and ordering, counting, 
and repeating compulsions; contamination obsessions and cleaning compulsions) 
require specifically tailored exposure exercises and cognitive therapy approaches to 
optimize treatment response (Sookman et al., 2005).  Interestingly, while treatment for 
OCD using ERP and/or CT has been available for some time, as evidenced by the number 
of meta-analyses available for review in this manuscript, relatively little attention has 
been paid to differential treatment outcome for specific symptoms.  A brief review of 
the available differential treatment findings are presented here. 
 In one study, Abramowitz et al. (2003; study 2) conducted ERP with 132 clients 
diagnosed with OCD.  After conducting cluster analyses on presenting symptoms, the 
clients were categorized as reporting primary symptoms as follows: harming, 
contamination, hoarding, unacceptable thoughts, and symmetry.  For the purposes of 
this discussion the outcome for hoarding will be excluded given the substantial 
differences in symptom presentation and unique treatment protocols developed for this 
disorder (Pertusa et al., 2010).  Following treatment, differential treatment outcome 
was shown, whereby clients with symmetry had the best treatment response (76% 
improvement), followed closely by contamination (70% improvement), with harming 
obsessions (59% improvement) and unacceptable thoughts faring the worst, with 46% 
improvement. 
 In a similar study design, Rufer et al. (2006) treated 104 clients diagnosed with 
OCD using CBT (both ERP and cognitive restructuring).  Primary symptoms reported 
were symmetry/ordering, contamination/cleaning, aggressive obsessions/checking 
rituals, and sexual/religious obsessions (again, hoarding will be excluded from this 
discussion for the reason noted earlier).  The authors found that those with 
contamination/cleaning symptoms had the greatest symptom improvement (60%) 
followed by aggressive obsessions/checking rituals (55.8%), symmetry/ordering (51%), 
and finally those with sexual/religious obsessions performing poorest (41.7%).   
 There are a number of compelling explanations for the variable outcome in 
treatment for different symptom dimensions of OCD.  These include: degree exposure 
exercises are readily designed to target the associated appraisals; logistical barriers to 
implementing exposure; and the perceived lag between exposure and anticipated 
outcome (for detailed discussion of these points, see McKay, Taylor, and Abramowitz, 
2010).  However, none of these possible explanations have garnered any substantive 
empirical base to draw meaningful conclusions and warrant further investigation. 
6. Barriers to Treatment Delivery 
The state of the science of ERP and CT for OCD can be considered well developed 
at this point.  However, there are some important challenges facing clients in receiving 
proper treatment. 
 6.1 Limited Number of Qualified Therapists and Challenges in Delivering 
Specialized OCD Therapy: 
             Conducting ERP is demanding for clinicians and a challenge for clients, 
particularly those who have severe symptoms (Abramowitz, Taylor, and McKay, 2005).  
There are important misunderstandings about the efficacy, safety, and tolerability of 
ERP, with clinicians holding these conceptions as much as clients Hembree and Cahill, 
2007).  Further, both ERP and CT involving behavioral experiments require well-
established therapeutic alliance in light of the demands of the clinical exercises (McKay, 
Arocho, and Brand, in press).  Specifically, therapeutic alliance requires that the client 
and therapist have a sound working relationship with the goals of treatment clearly 
delineated, and the interventions understood to lead meaningfully to symptom relief.  
The nature of ERP and CT with the associated behavioral experiments leads to evocation 
of fear reactions.  The degree that alliance is secured would therefore be essential for 
successful ERP or CT.  Indeed, Maher et al. (2012) found therapeutic alliance to be a 
predictor of treatment outcome in a recent trial of CBT for OCD. At the same time, it has 
been reported with OCD and other clinical populations that, unsurprisingly, among the 
strongest predictors of therapeutic alliance is symptom change (Shafran et al., 2009).  
Further research is required to examine therapist and intervention characteristics, in 
interaction with patient variables that optimize adherence to treatment that is essential 
to symptom reduction. 
 Hembree and Cahill (2007) and others have noted that there is a severe dearth 
of therapists qualified to deliver exposure based and cognitive therapies in some 
countries. McHugh and Barlow (2010) reviewed several well-developed and carefully 
implemented programs designed to improve the clinicians’ reliance on empirically 
supported methods.  The results were discouraging, with many clinicians improving in 
their treatment delivery shortly after the training, but soon after returned to the former 
and less empirically-based method of therapy.   
 As a means of combating the problem of limited reliance on empirically 
supported methods in treatment, Klepac et al. (2012) developed a blueprint for doctoral 
training in clinical psychology that emphasizes the essential elements to practice using 
scientific grounded methods.  However, there are insufficient doctoral programs in 
Canada and the US that offer an elective rotation in specialty treatments for OCD. 
 Aside from training at the doctoral level or the implementation of specific 
training programs tailored to specific disorders, policies have been implemented in 
some countries that require specific training in order to treat OCD (as well as other 
mental health conditions).  To cite one prominent example, the National Institute for 
Health and Clinical Excellence (2005) outlines general procedures necessary for 
assessing and treating OCD, and includes recommendations for specific levels of care 
based on severity.  These guidelines include specific components for educating patients 
about specific aspects of the condition, the extent to which obsessions are experienced 
in the general population, and information about the types of obsessions that are typical 
for sufferers of OCD.  The portion regarding symptom dimensions includes 
contamination fears/washing compulsions; checking; intrusive thoughts regarding 
harming others, sexual behaviors, and religiosity; obsessional slowness; and 
symmetry/ordering obsessions and compulsions.  The guidelines go on to recommend 
different levels of care, with specific numbers of sessions or therapist contact hours 
based on severity and tolerance for ERP. These recommendations describe the 
necessary qualifications of therapists to deliver services to individuals with OCD.  The 
formation and implementation of the National Institute of Clinical Excellent (NICE) 
guidelines has been hailed as the largest and most ambitious provision of mental health 
services undertaken to date (Piling, 2012).  Evaluations of the efficacy of this program 
have shown promise in improving the level and access to proper care for OCD 
(Drummond et al., 2008; Clark, 2011). 
 Additional educational and training programs are needed in primary through 
tertiary care settings to improve early detection, accurate diagnosis, and appropriate 
timely referral.  In our view, certification and accreditation in specialty treatments for 
OCD is the next crucial step required to achieve transformative international  impact on 
care for this disorder, to meet the urgent treatment needs of OCD sufferers. 
Development of certification criteria will entail detailed operationalization by the CIOCD 
expert Accreditation Task Force of essential specialty assessment and treatment 
competencies, didactic, clinical and supervisory processes of dissemination of these 
competencies, and criteria for professional candidacy (please see Sookman and 
Fineberg, Introduction, this series). 
 6.2 Resistant and Refractory Case Presentations:  A subset of OCD sufferers is 
classified treatment non-responders, namely as either resistant or refractory to all 
empirically based treatments, CBT or medication.  Consensus in definition of what 
constitutes either refractory or resistant has not been developed at this point, and there 
are several competing conceptualizations in the literature (discussed in Tolin et al., 
2004).  Refractory or resistant cases typically refers to clients who have sought out, and 
participated in (albeit not fully), properly developed CBT for OCD, and yet failed to 
benefit from treatment. It has been estimated that approximately 30% of OCD sufferers 
fail to respond to any empirically based intervention, including psychopharmacotherapy 
(Schruers et al., 2005).   
 Several studies have examined a variety of definitions for treatment non-
responder.  For instance, Tolin et al. (2004) defined psychopharmotherapy 
nonresponders as any OCD sufferer who failed to benefit from at least two adequate 
trials of medications used to treat the condition.  However, more extreme definitions of 
nonresponder have been offered, with the most severe being offered by Jenike and 
Rauch (Jenike and Rauch, 1994). In this case, nonresponder was defined as any OCD 
sufferer who failed to benefit from any therapeutic intervention developed for the 
disorder.   Consideration of stepped care models such as that described in the NICE 
guidelines (2005) provides recommendations for more intensive treatment and a team-
based approach to treating nonresponders.  
 
7. General Recommendations and Future Directions  
 The research reviewed in this article highlights several important dimensions of 
how to conceptualize and execute treatment for OCD.  While the growth of the 
treatment literature for OCD has been impressive since Meyer (1966) first employed 
ERP with two clients with the condition, there are a number of important limitations in 
our knowledge of treatment. In light of the abundance of evidence supporting the 
application of ERP, this treatment should be predominant in first-line evidence based 
psychological interventions for OCD.  Cognitive therapy has demonstrated efficacy and, 
as discussed above, at this point in order to address the heterogeneity and complexity 
of the OCD most experts recommend that CT should be administered in combination 
with ERP.  CT with ERP can be administered with comparable aims of CT with behavioral 
experiments (McMillan and Lee, 2010).  The primary distinction is that CT with 
behavioral experiments aim to actively challenge the appraisals while they are most 
relevant to the client. CBT, comprising CT and ERP, also often aims to address and 
modify the OCD-related fear structure and address the hypothesized underlying 
cognitive features of the disorder.  
 Despite the success of ERP, there are limitations.  First, as noted previously, 
adherence to treatment hinders outcome (Maher et al., 2010; Simpson et al., 2011; 
Maher et al., 2012; Simpson et al., 2012).  Further, while those who complete treatment 
typically have good outcome, many patients with OCD either fail to initiate treatment or 
drop out, which has in turn led to the recommendation of adding CT to the treatment 
protocol (Daflos and Whittal, 2012).  Finally, problems remain in understanding how to 
best improve symptoms for several major dimensions of the disorder.  Notably, some 
forms of checking and sexual or religious obsessions remain a significant challenge for 
treatment.  Checking is a well-known and common symptom of the disorder, and 
represents a significant proportion of participants in treatment trials (Ball, Baer, and 
Otto, 1996), however, the heterogeneity of appraisals and neutralizing strategies 
reported by checkers (Foa and Kozak, 1986) highlights the need for further research on 
more difficult to treat dimensions. Additionally, a search of the literature revealed no 
systematic examinations of how to treat religious and/or sexual obsessions.  Other 
complicating factors, such as overvalued ideas (Foa and Kozak, 1986; Kozak and Foa, 
1994) likewise merit systematic examination in order to devise interventions for the full 
range of clinical presentations of the disorder.   Figure 1 illustrates the relationship 
between the recommended first line treatment and the additional suggestions based on 
the limited research for the aforementioned unique symptom presentations. 
 Fortunately at this point we are able to treat and provide symptom relief to a 
large percentage of OCD sufferers and associated symptoms, such as depression 
(Olatunji et al., 2013) and personality disorders (Dettore, Pozza, and Coradeschi, 2013).  
Approximately 50% of OCD sufferers benefit from ERP alone (e.g., Foa et al., 2005). 
Patient treatment adherence (Simpson et al., 2011) warrants further examination since 
it is not yet clear how to improve outcome in the non-adherent patient.  Further, recent 
findings suggest that many clients drop out because of fears of conducting exposure, 
and inaccurate beliefs about methods of implementation prevent many clients from 
initiating treatment or remaining in treatment until symptoms remit (Mancebo et al., 
2011).  A summary of our recommendations for treatment is also presented in Figure 2. 
 First, while we have highlighted the theoretical and intervention differences that 
are hypothesized to underlie CT and ERP, there is sufficient evidence that the 
bidirectional relationship between the two interventions (cognitive change leads to 
behavioral improvement; exposure leads to cognitive change) makes the distinction 
unnecessary.   Case conceptualization, clinical setting, symptoms subtypes and severity, 
and clinician characteristics may contribute to decisions about the method of 
administering treatment.  
 Second, careful assessment for adherence is essential throughout the course of 
treatment.  This is an important component of effective treatment (Simpson et al., 
2011), and every effort should be made to assess the varied reasons for resistance 
treatment (e.g., fear of illness, calamity, or distress, risk aversion, etc.) and to further 
develop interventions to address adherence to the demands of CBT.  In addition to 
clinical interview, administration of the Patient ERP Adherence Scale (PEAS; Simpson et 
al., 2011) is recommended to assess levels of adherence and whether additional 
intervention is necessary to foster improvement.  Recent efforts to improve adherence 
have not yet shown success (such as with Motivational Interviewing, MI [Simpson et al., 
2011]) and therefore, further research into methods to improve adherence are 
warranted.  The specific factors that may affect resistance during CBT for OCD require 
examination. Intransigence of symptom related dysfunctional beliefs, intolerance of 
distress, risk aversion, and difficulty with sustained adaptive learning  are other factors 
that may impact collaboration and outcome. For discussion and illustration of the 
complexity and diversity of hypothesized reasons for resistance during CBT for OCD, see 
Sookman and Steketee, 2010. 
 Third, severity of symptoms often warrants greater intensity and therapist –
assistance during treatment.  Many patients do not respond to in office ERP because 
their fears occur only at home, at school/work, or in public places and/or are able to 
initially  participate in ERP only when assisted by the therapist. In our view, among the 
serious difficulties with “stepped care” approaches is that this model of intervention 
may be utilized primarily due to paucity in many regions of clinicians sufficiently trained 
and experienced with empirically based specialty CBT for OCD, rather than predicated 
on empirically based rationale for determining level of care necessary based on severity 
of symptoms. Recent efforts to deliver treatment to a wider range of patients, using 
internet delivered approaches, has had some success and could provide promise in 
alleviating symptoms in individuals who do not live near recognized providers.  To 
illustrate, in one recent trial Andersson et al. (2012) treated a large sample (n=101) with 
a ten week internet delivered CBT program compared to a control group and found 
significant improvement (d=1.12) in symptoms.   
A crucial priority for further clinical research is examination of the specific 
therapeutic ingredients that impact outcome and optimize recovery for different OCD 
symptom subtypes. Most published treatment trials of CBT are short term.  As Steketee 
et al., (2011) and other authors have noted, longer term therapy is often indicated for 
more severe cases. Importantly, immediate treatment at a tertiary care specialty OCD 
Clinic may avert progression to chronicity, disability, and intransigence of symptoms for 
initially mildly ill sufferers. A major challenge for the future is to improve recovery rates 
following treatment for OCD, as defined by no longer meeting diagnostic criteria for 
OCD (e.g., YBOCS = or < 7, [Sookman and Steketee, 2010]). This may necessitate prompt 
and non-time limited specialty treatment in the hands of an OCD expert as soon as 
possible following symptom onset. Given that OCD is a severe, debilitating disorder, and 
given the current availability of effective evidence based treatments, the paucity of 
qualified specialists is a central issue in the field. Dissemination of expertise in available 
evidence based treatments for OCD is urgently required.  
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Disclaimer: The advice we are providing is as accurate and comprehensive as 
possible but it is only general advice and it is up to clinicians reading this paper to 
make their own clinical judgment when interpreting the information and deciding 
how best to apply it to the treatment of patients. Patients should not use this 
information as a substitute for the individual advice they may receive from 
consulting their own doctor. 
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Highlights 
 
• Cognitive Behavior Therapy (CBT) has been examined and established as a well 
supported treatment for Obsessive
• The availability and delivery of CBT has not been matched by its established efficacy
• A review of the efficacy, complications in treatment delivery, and prognostic barriers to 
outcome is provided. 
• Recommendations are made to improve and expand treatment delivery for OCD
 
-Compulsive Disorder (OCD) 
 
 
 
 
 
